Patents Assigned to Actavis, Inc.
  • Modified release tranexamic acid formulation
    Patent number: 9387178
    Abstract: A modified release dosage form for the oral administration of tranexamic acid.
    Type: Grant
    Filed: November 19, 2013
    Date of Patent: July 12, 2016
    Assignee: Actavis, Inc.
    Inventors: Mayank R. Joshi, Shahin Fesharaki
  • Frangible Shipping Carton and Associated Methods
    Publication number: 20160068299
    Abstract: A selectively frangible shipping carton for storing and shipping goods comprises at least one side wall joining a top wall and a bottom wall. A path of weakness extends around a periphery of the carton through at least a portion of the side wall. The path of weakness enables a user to manually separate the carton into at least two portions: an upper portion including the top wall and a lower portion including the bottom wall. A pair of lines of weakness extends upwardly relative to the path of weakness and terminates at or adjacent the top wall. A grip flap defined in the side wall between the pair of lines of weakness, the grip flap being graspable by the user when separating the carton into the at least two portions.
    Type: Application
    Filed: November 17, 2015
    Publication date: March 10, 2016
    Applicant: ACTAVIS, INC.
    Inventor: John Bitner
  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 9060941
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Grant
    Filed: March 30, 2005
    Date of Patent: June 23, 2015
    Assignees: ACTAVIS, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Unchalee Lodin, Jack Cardinal, Avinash Nangia, Kazuhiro Okochi
  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 8668931
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Grant
    Filed: May 8, 2013
    Date of Patent: March 11, 2014
    Assignee: Actavis, Inc.
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia
  • Administration of non-oral androgenic steroids to women
    Patent number: 8551516
    Abstract: The present invention provides compositions, methods, and kits for improving health in a woman having elevated SHBG levels, or who is receiving oral estrogen supplementation, by non-orally administering an effective amount of an androgenic steroid. Further, the present invention provides compositions, methods, and kits for coadministering an effective amount of an orally administered estrogen and an effective amount of a non-orally administered androgenic steroid for women in need of estrogen supplementation.
    Type: Grant
    Filed: February 15, 2007
    Date of Patent: October 8, 2013
    Assignee: Actavis, Inc.
    Inventors: Theresa Rosario-Jansen, Norman A. Mazer